Next
time you are in line at the pharmacy waiting to pick up your prescription,
try to guess which customers are paying the very highest price for their
medications. It shouldn't be hard. Look for the poorest, oldest,
and sickest person and you can be pretty certain you picked right.
Two
studies prove the sad truth about who is paying extortionist prices for
their prescription drugs. I asked the Democratic staff of the Government
Reform Committee to compare the amount of money paid by Medicare beneficiaries
who don't have prescription drug insurance coverage with the costs charged
to the drug companies' most favored customers – HMOs, insurance companies,
the Veteran's Administration, etc. They looked at the five prescription
drugs most often used by the elderly. I was startled to find that
these senior citizens and persons with disabilities were paying a whopping
114% more on average for their drugs than the most favored customers.
That's right. The people who most need medications and who can least
afford them are being gouged by the pharmaceutical companies. The
study confirmed, by the way, that your local drug store is not causing
those high prices.
If
you are without a prescription drug benefit, you won't be surprised by
this example. An insured patient fills his prescription for Zocor,
a cholesterol drug produced by Merck. The cost is $34.80. A
75 year old woman without insurance is charged $105.75 for the same drug,
same amount, same everything, except same price. She is paying 204%
more! Is it any wonder that she may just put her doctor's prescription
in a drawer, or cut the pills in half, or take only one or two pills a
week, or forgo the fruits and vegetables that she needs to eat, or not
pay her heat or electric bill? These are the unhappy options faced
by a growing number of frail Americans.
Our
senior citizen might be wise to pack a bag and make a special trip to Canada
or Mexico – not to vacation, but rather to buy her drugs. The second
study I commissioned compared the prices charged for the same frequently
used drugs and found that they cost 83% less in Canada and 81% less in
Mexico. I don't mean the Mexican or Canadian version of those drugs
or a generic brand. I mean the exact same drugs – same manufacturer,
same packaging, same quality. The Zocor that she purchased for $105.75
around the corner will cost $46.17 in Canada, a 129% savings, and $67.65
in Mexico, a 56% savings. If she and her friends could scrape the
money together to make the journey, it could be worth it. Travel
agents take note!
Ask
the drug companies how they justify this discriminatory pricing, and they
will tell you that any decrease in the cost of drugs will result in their
inability to do the research and development necessary to bring new lifesaving
medications to market. What bunk! This is the most profitable
industry in the world, exceeding the profits of the Fortune 500 by 2.3
times. The investment company of Merrill Lynch, responding to concerns
about legislation that could lower drug prices, predicted that a 25% reduction
in prices would barely affect profits, according to Merrill Lynch.
Besides, a look at their books proves that far more money is spent on advertising
than on research and development. And some of what they call research,
is marketing research or research into boutique kinds of drugs for an upscale
market.
As
a member of the U. S. Congress, I hear from people every day who simply
can't afford the medications that they need to keep them well, or in some
cases, alive. I tell them about proposals that I am supporting that
would really help them. I am one of 137 members of the House of Representatives
sponsoring a measure that would allow pharmacies to purchase drugs for
Medicare beneficiaries at the same low prices available to the Federal
government and other favored customers, including HMOs and insurance companies.
This legislation, HR 664, would reduce drug prices by about 40%.
As you can imagine, the wealthy drug industry is fighting us tooth and
nail, or should I say dollars and cents, showering members of Congress
with contributions. They're far more worried about those top executive
salaries than they are about poor seniors.
President
Clinton had it right when he proposed prescription drug coverage as a Medicare
benefit. The drug companies are opposing that too, even though more
taxpayer dollars would go to them. They're worried that Medicare
coverage will lead to price controls – and if we have half a brain, it
will. The pharmaceutical giants paid an attractive older woman they
call "Flo" to appear in TV and newspaper ads warning senior citizens to
"keep government out of my medicine cabinet." Speaking for myself,
I want the government in my medicine cabinet making sure that the medicines
I take are safe and effective. And I sure wouldn't mind it if government
forced those greedy drug companies to lower their prices.
Sure
the drug companies are rich, but that doesn't mean that they get to call
all the shots. As a long time organizer and activist and an elected
official for nine years, I am telling you on good authority that people
power trumps the money every day of the week. If we want lower drug
prices, we can have them. The battle is just beginning. I'd
love to know what you think about this. Contact my Chicago office
at 5533 N. Broadway, 773/506-7100 or email me at jan.schakowsky@mail.house.gov.
|